Buscar
Mostrando ítems 1-10 de 321
Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine
(Taylor and Francis, 2019)
Background: This exploratory analysis was conducted to characterize the level of HPV types 6/11 antibodies in peripartum maternal blood and in cord blood of infants born to women who received 9-valent HPV (9vHPV) vaccine ...
Seroprevalence of Human Papillomavirus 6, 11, 16, and 18 in Young Primiparous Women in Sao Paulo, Brazil
(LIPPINCOTT WILLIAMS & WILKINS, 2010)
Introduction: Data on epidemiology of HPV infection are needed for the development of human papillomavirus (HPV) vaccine recommendations, especially in countries where HPV vaccination is not yet included in public vaccination ...
Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers
(Elsevier, 2012)
Two hundred female sex workers (FSWs) in Lima, Peru were randomized to receive HPV4 vaccine in the standard (0, 2, 6 months) or a modified schedule (0, 3, 6 months). One hundred and eighty four (92%) participants completed ...
Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study
(Biomed Central Ltd, 2014-11-18)
Background: Immunity plays an important role in controlling human papillomavirus (HPV) infection and associated lesions. Unlike infections caused by other viruses, natural HPV infection does not always result in a protective ...
Altered immune response in benign HPV positive genital lesions
(Universidade Estadual Paulista (Unesp), 2017-09-15)
Introdução. A infecção por Papilomavírus humano (HPV) está relacionada a doenças benignas e malignas, sendo o grau de patologia dependente do tipo viral, da resposta imune do hospedeiro e de fatores ambientais. O condiloma ...
Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens
(Microbiology Soc, 2020-01-01)
Introduction. Persistent human papillomavirus (HPV) type 16 infection is the main causal agent of cervical cancer. Most HPV infections clear spontaneously within 1-2 years. Although not all infected women develop detectable ...